Pictet Asset Management
IDYA icon

Pictet Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Pictet Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6M Sell
712,674
-3,232
-0.5% -$98.9K 0.03% 473
2026
Q1 		$23.9M Sell
715,906
-18,429
-3% -$618K 0.03% 465
2025
Q4 		$25.4M Sell
734,335
-298,664
-29% -$9.52M 0.02% 469
2025
Q3 		$28.1M Sell
1,032,999
-772,137
-43% -$18.7M 0.03% 448
2025
Q2 		$37.9M Sell
1,805,136
-33,628
-2% -$645K 0.04% 365
2025
Q1 		$30.1M Sell
1,838,764
-102,507
-5% -$2.18M 0.03% 396
2024
Q4 		$49.9M Buy
1,941,271
+46,931
+2% +$1.33M 0.05% 297
2024
Q3 		$60M Buy
1,894,340
+306,841
+19% +$11.6M 0.07% 264
2024
Q2 		$55.7M Buy
1,587,499
+314,653
+25% +$12.5M 0.06% 265
2024
Q1 		$55.9M Buy
1,272,846
+397,099
+45% +$17.1M 0.06% 290
2023
Q4 		$31.2M Buy
+875,747
New +$26.1M 0.03% 382

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Pictet Asset Management's IDYA Position: Q2 2026 in Review

Pictet Asset Management reduced its IDEAYA Biosciences (IDYA) stake by 0.45% in Q2 2026, selling an estimated $98.9K and leaving 712,674 shares worth $26.6M. The position accounts for 0.03% of the portfolio, ranked #473.

Pictet Asset Management first reported a position in IDYA in Q4 2023 and has held it in 11 quarters since. The position peaked at $60M in Q3 2024. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Pictet Asset Management held 712,674 shares of IDEAYA Biosciences worth $26.6M as of Q2 2026.
  • Pictet Asset Management sold 3,232 IDEAYA Biosciences shares in Q2 2026, an estimated $98.9K.
  • IDEAYA Biosciences made up 0.03% of Pictet Asset Management's portfolio in Q2 2026, its #473 holding.
  • Pictet Asset Management first reported a position in IDEAYA Biosciences in Q4 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's IDEAYA Biosciences position peaked at $60M in Q3 2024.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.